Clinical trial Recruiting at 1 site Observational Ages 18 and up

Neobone® safety and performance in dental bone grafting

Official title: Evaluation of the Safety and Performance of the Neobone®: A Prospective Observational Study in Dental Area

Run by Bioceramed · NCT07179497 · Data updated 2026-11-12

This project will collect real-world data to see if Neobone® is safe and helps bone heal in adults having reconstructive dental procedures.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment66 (estimated)
SponsorBioceramed
Industry-sponsored
Drugs / interventionsradiation
Locations1 site (Lisbon)
StatusRecruiting
StartedOctober 6, 2025
Main results expectedOctober 2027
Study endsOctober 2027
Registry record updatedJune 18, 2026
Trial IDNCT07179497 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) undergoing reconstructive dental or maxillofacial surgery where the surgeon plans to use Neobone® and who can give informed consent are the intended participants.

Probably not a fit

Patients who require structural load-bearing support, have active local or systemic infections, metabolic bone disorders, unstable implantation sites, or known hypersensitivity to the implant materials are unlikely to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Neobone® is a synthetic, resorbable biphasic calcium phosphate (hydroxyapatite and beta‑tricalcium phosphate) bone substitute intended for use in dental and maxillofacial grafting. This prospective observational study will gather clinical and safety data from adults who receive Neobone® during reconstructive dental surgery at the participating center. Collected information will include handling, wound healing, radiographic and clinical signs of bone integration, and any adverse events during follow-up. The results are intended to provide clinical evidence to support the device's performance and safety profile.

Why it matters

Potential benefit: If successful, Neobone® could provide a resorbable synthetic graft that supports bone regeneration and may reduce the need to harvest a patient’s own bone.

How similar studies have gone: Other clinical reports of biphasic hydroxyapatite/β‑TCP bone substitutes have shown positive bone integration in dental augmentation, but long-term device-specific evidence for Neobone® remains limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult males or females (age \> 18 years old);
* Patients who are able to sign an informed consent form (for data collection);
* Patients undergoing reconstructive dental surgery and indicated for the use of Neobone®;

Exclusion Criteria:

* Patients who are unable to understand consent and the objectives of the study;
* Signs of local or systemic acute/ active or chronic infections;
* Metabolic affections;
* Severe degenerative diseases, conditions in which general bone grafting is not advisable;
* Implementation sites that allow product migration;
* Conditions which require structural support in the skeletal system;
* Conditions where the implantation site is unstable and not rigidly fixated;
* Sensibility to the implantable materials;
* Known hypersensitivity to the implant material.

Where it's running

  • Egas Moniz School of Health and Science Caparica
    Lisbon, Portugal
    Recruiting

Study contacts

  • Principal investigator: João Botelho — Egas Moniz School of Health and Science Caparica
  • Study coordinator: Alexandre Barros
  • Email: info@bioceramed.com
  • Phone: 253 573 460

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.